Literature DB >> 7173276

Phenobarbital induction of procyclidine metabolism: in vitro study.

G Paeme, H Van Bossuyt, A Vercruysse.   

Abstract

After pretreatment of adult male Wistar rats with phenobarbital, a well-known cytochrome P-450 inductor, the liver microsomal cytochrome P-450 content increased significantly compared to that of control rats. At the same time the amount of procyclidine, metabolized by the 9000 g supernatant fraction of rat liver homogenate fortified with a NADPH generating system, increased significantly as well. However when related to the liver microsomal cytochrome P-450 content, the amount of metabolized procyclidine does not differ anymore between phenobarbital treated and control rats. Therefore phenobarbital induces the in vitro metabolism of procyclidine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173276     DOI: 10.1007/BF03189569

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Kemadrin in the treatment of parkinsonism.

Authors:  R S SCHWAB; M E CHAFETZ
Journal:  Neurology       Date:  1955-04       Impact factor: 9.910

2.  Determination of drug metabolizing enzymes in needle biopsies of human liver.

Authors:  B Schoene; R A Fleischmann; H Remmer; H F von Oldershausen
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

3.  A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.

Authors:  R H Mindham; P Lamb; R Bradley
Journal:  Br J Psychiatry       Date:  1977-06       Impact factor: 9.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.